After 40 Years In Nutritional Biochemistry, This Is What I Wish Every Newly Diagnosed Patient Knew About Their Blood Pressure.

A retrospective from the Chief Science Officer of a longevity research company, drawing from four decades of work in the field. The science is settled. The conversation in your doctor's office should look different than it does.

By Dr. Luke Bucci, PhD · Chief Science Officer, Juvenon ✓ Verified Expert

May 2026

Dr. Luke Bucci, PhD, Chief Science Officer at Juvenon. Forty years in nutritional biochemistry. Has mapped 13 of Juvenon's 46 nutrients to Nobel-Prize-winning research. (Photo: Daily Health Briefs)

I have spent forty years in nutritional biochemistry.

I have a PhD. I have published. I have served as a senior scientist or science officer at four supplement and longevity companies. I have read more papers on cardiovascular signaling than I can reasonably count, and at this point in my career, I have stopped being surprised by what newly diagnosed patients are not told at their first appointment.

I want to use this article to say what I would say to a newly diagnosed patient if they sat across from me at my desk for an hour, instead of across from their doctor for ten minutes.

I am not here to undermine your doctor. Your doctor is doing the job their schedule allows them to do. They are not lying to you. They are triaging. There is a difference.

I also understand the moment you are probably in right now. There is a good chance you are reading this not long after that appointment, with the new prescription still sitting on your kitchen counter. You have read the side effects. You are wondering whether this is the rest of your life now, whether you will still feel like yourself, and whether there was something you could have done sooner. Those are fair questions. No one in a ten-minute appointment has the time to answer them. That is what this article is for.

But there are things I know, after forty years in this field, that I think every newly diagnosed patient deserves to hear plainly. Here they are.

Dr. Luke's working desk. Forty years of notes. The fundamentals of cardiovascular biochemistry have not changed in that time. The conversation patients have with their doctors, mostly, has not either.

What Your Doctor Is Treating Versus What Is Actually Happening

When your physician hands you a prescription for blood pressure medication, what they are doing, in technical terms, is targeting one of two downstream regulatory systems. Most commonly the renin-angiotensin-aldosterone system, or the calcium channel system in your blood vessel smooth muscle. These are good targets. The drugs that hit them are well-studied and largely work.

But blood pressure is not produced by just two systems. It is produced by at least six. Heart contraction force. Blood vessel diameter. Total blood volume. Kidney filtration. Autonomic nervous system tone. Endothelial function.

Of those six, the standard prescription addresses two. The other four are doing whatever they are doing, and largely going unaddressed.

That is not a criticism of medication. Medication is doing its part. It is a description of what medication is, and what it is not.

The standard prescription is doing what it is designed to do. It is addressing two of the six systems that govern blood pressure. The patient who learns to address the other four is the patient who feels noticeably better.

The Discovery That Changed Cardiovascular Science (And Did Not Make It Into Patient Education)

In 1998 the Nobel Prize in Physiology or Medicine was awarded for the discovery of nitric oxide as a signaling molecule in the cardiovascular system. This was, in our field, a landmark event. It rewrote a fundamental chapter of how we understand blood vessel function.

To summarize. Your blood vessels are not passive plumbing. They are active. They constantly relax and contract in response to a chemical signal. That signal is a small, short-lived gas molecule called nitric oxide. When nitric oxide production is adequate, your vessels relax appropriately and blood flows freely. When production drops, your vessels remain slightly constricted, your heart works harder than it should, and your pressure climbs.

The production of nitric oxide in the human body follows a predictable curve over a lifetime. It peaks in the early twenties. By age 40, the average healthy adult is producing roughly half of what they produced at peak. By age 60, approximately fifteen percent.

By the time someone is sitting in an appointment being told they have stage 1 or stage 2 hypertension, the underlying decline in their nitric oxide production has, in almost every case, been quietly progressing for two decades. This is not the only cause of age-related hypertension. It is, however, one of the most consequential ones, and one of the most addressable.

The Two Pathways

Your body makes nitric oxide through two separate pathways, and both can be supported through nutrition. You should know what they are, because the difference explains why most supplements fall short.

The first is the L-arginine pathway. Your body converts the amino acid L-arginine into nitric oxide inside the lining of your blood vessels. This is the on-demand system that keeps your vessels relaxed throughout the day.

The second is the dietary nitrate pathway. The nitrate in leafy greens and beets is converted, by bacteria in your mouth and gut, into nitric oxide. This is the slower, food-derived route.

These two pathways do not replace each other. They work in parallel, and an older adult with rising blood pressure usually has impairment in one or both. Supporting only one is doing half the job. A beetroot-only product covers the second pathway. A plain L-arginine product covers the first. A product worth taking covers both.

The published literature on the two NO pathways spans roughly two decades. The implication for newly diagnosed patients, in my view, has not been adequately translated into clinical practice.

Why Most Commercial NO Supplements Do Not Move The Needle

When I evaluate a cardiovascular formula, I look at three things, in this order: form, dose, and combination.

1. Form of the active ingredient.

Standard L-arginine is largely broken down in the gut before it reaches your bloodstream, so the results are modest. A patented form called Nitrosigine® pairs L-arginine with a stabilizing silicate and has been shown in published studies to raise blood arginine levels and sustain them for up to six hours per dose. Most products on the shelf still use the cheaper, less absorbable form.

2. Dose of the active ingredient.

This is the one I see most often. The label lists the right ingredient, but the amount in the capsule is a small fraction of the dose used in the clinical study, usually hidden inside a proprietary blend. If a product will not disclose the dose of each ingredient, assume the dose is too low. Forty years has not given me an exception to that rule.

3. Combination strategy.

A product that supports only one pathway leaves the other unsupported. The arteries also have to be flexible enough to respond once the nitric oxide signal arrives, which is why trans-resveratrol, at clinical dose, belongs in the formula for arterial flexibility. A complete product covers both pathways and arterial flexibility.

Most commercial supplements fail at least one of these tests. A few pass all three. The one I formulated, BloodFlow-7®, was designed specifically to pass all three.

What I Formulated, And Why

BloodFlow-7® is the cardiovascular formulation I co-developed at Juvenon. I want to be transparent about that. This article is sponsored by Juvenon. I am their Chief Science Officer. I have a financial relationship with the product. I am also a scientist with forty years in the field and I would not put my name on a formulation I did not believe in.

The formula is built around four components, each at the dose used in the supporting clinical studies, with full label transparency and no proprietary blends.

1. Nitrosigine® (patented arginine plus inositol-stabilized silicate).

Addresses the L-arginine pathway. Unlike standard L-arginine, which breaks down in the gut before it reaches the bloodstream, Nitrosigine® is a patented bonded complex shown in peer-reviewed studies to raise blood arginine levels for up to six hours per dose, keeping the raw material your body needs to make nitric oxide available, not wasted.

2. S7® botanical complex.

Addresses the dietary nitrate pathway, plus broader endothelial support, via seven plant-derived polyphenol sources (green coffee, green tea, turmeric, tart cherry, blueberry, broccoli, kale). Provides a second route of nitric oxide production that does not depend on individual variability in oral microbiome.

3. Trans-resveratrol at clinical dose.

Supports arterial flexibility and flow-mediated dilation. Published clinical research has shown an effect of up to 62 percent improvement in arterial dilation at clinical dose. This is the component that ensures the arteries can actually respond to the nitric oxide signal once it is produced.

4. BioPerine®.

A standardized extract of black pepper used as a bioavailability enhancer. Ensures that the active ingredients above actually cross into the bloodstream rather than being metabolized or excreted.

Four components. Both pathways. Clinical doses. Full label transparency. Backed by peer-reviewed research from institutions including the Whitaker Cardiovascular Institute and San Francisco State University.

"A meaningful cardiovascular product has to address both nitric oxide pathways and provide the trans-resveratrol component that allows the arteries to respond. Anything less is doing half the job." Dr. Luke Bucci, PhD

What I Would Tell A Newly Diagnosed Patient

So here is the part that matters most. You do not need to understand every pathway I just walked through. You need to know what to do with it. If you were newly diagnosed and sitting across from me at my desk, this is exactly what I would tell you, starting today.

1. Take your medication.

Your physician prescribed it for a reason and it is doing meaningful work on two of the systems that produce your blood pressure. Do not stop taking it without speaking with your doctor.

2. Do the lifestyle work.

Reduce sodium. Move daily. Lose ten pounds if you have them to lose. Stop smoking. Drink moderately or not at all. None of this is new. All of it matters.

3. Address the upstream systems your medication is not touching.

Specifically, the nitric oxide system. Use a supplement that supports both pathways, at clinical dose, with a trans-resveratrol component, in a transparent formulation. There are not many products that meet all those criteria. I formulated one because I could not find one I was satisfied with on the market.

4. Be patient.

Real cardiovascular change is measured in months, not days. Give any intervention at least 60 to 90 days before evaluating it. Your Sunday morning readings, taken at the same time and in the same conditions each week, are your most reliable data point. Track them.

5. Talk to your doctor.

If your readings begin to trend downward, your doctor may need to adjust your medication. This is a conversation to have. The goal is not to keep adding interventions on top of each other. The goal is to address the systems that are actually impaired.

★★★★★ What Verified Customers Are Saying

Dr. Luke Bucci, PhD

Chief Science Officer · Juvenon

Dr. Luke Bucci has spent forty years in nutritional biochemistry. His career innovations include:

• Pioneering whey protein isolates and the first whey protein drinks for muscle building.
• Creating the first synergistic formula combining glucosamine and chondroitin for joint health.
• Introducing krill oil as a superior alternative to fish oil and helping patent the "MEGA RED" supplement.
• Reimagining multivitamin design at Ritual with essential nutrients for targeted groups.